These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 20229604)

  • 21. Comparative studies of the in vitro metabolism and covalent binding of 14C-benzene by liver slices and microsomal fraction of mouse, rat, and human.
    Brodfuehrer JI; Chapman DE; Wilke TJ; Powis G
    Drug Metab Dispos; 1990; 18(1):20-7. PubMed ID: 1970773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inter-species comparison of liver and small intestinal microsomal metabolism of fluoranthene.
    Walker SA; Whitten LB; Seals GB; Lee WE; Archibong AE; Ramesh A
    Food Chem Toxicol; 2006 Mar; 44(3):380-7. PubMed ID: 16182425
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes.
    Obach RS
    Drug Metab Dispos; 1999 Nov; 27(11):1350-9. PubMed ID: 10534321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interspecies comparison of the glucuronidation processes in the man, monkey, pig, dog and rat.
    Matal J; Jancova P; Siller M; Masek V; Anzenbacherova E; Anzenbacher P
    Neuro Endocrinol Lett; 2008 Oct; 29(5):738-43. PubMed ID: 18987594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation.
    Ramsdell HS; Eaton DL
    Cancer Res; 1990 Feb; 50(3):615-20. PubMed ID: 2105159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
    Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA
    Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 3: comparative assessement of prediction methods of human clearance.
    Ring BJ; Chien JY; Adkison KK; Jones HM; Rowland M; Jones RD; Yates JW; Ku MS; Gibson CR; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4090-110. PubMed ID: 21541938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase I metabolism of ganstigmine. Rat, dog, monkey and human liver microsomal extracts investigated by liquid chromatography electrospray tandem mass spectrometry.
    Catinella S; Pelizzi N; Puccini P; Marchetti S; Zanol M; Acerbi D; Ventura P
    J Mass Spectrom; 2001 Dec; 36(12):1287-93. PubMed ID: 11754120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolism and covalent binding of [14C]toluene by human and rat liver microsomal fractions and liver slices.
    Chapman DE; Moore TJ; Michener SR; Powis G
    Drug Metab Dispos; 1990; 18(6):929-36. PubMed ID: 1981539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioactivation and irreversible binding of the cognition activator tacrine using human and rat liver microsomal preparations. Species difference.
    Woolf TF; Pool WF; Bjorge SM; Chang T; Goel OP; Purchase CF; Schroeder MC; Kunze KL; Trager WF
    Drug Metab Dispos; 1993; 21(5):874-82. PubMed ID: 7902251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biotransformation of a novel antimitotic agent, I-387, by mouse, rat, dog, monkey, and human liver microsomes and in vivo pharmacokinetics in mice.
    Ahn S; Kearbey JD; Li CM; Duke CB; Miller DD; Dalton JT
    Drug Metab Dispos; 2011 Apr; 39(4):636-43. PubMed ID: 21233217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interspecies prediction of human drug clearance based on scaling data from one or two animal species.
    Tang H; Hussain A; Leal M; Mayersohn M; Fluhler E
    Drug Metab Dispos; 2007 Oct; 35(10):1886-93. PubMed ID: 17646280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biotransformation of the anti-angiogenic compound SU5416.
    Antonian L; Zhang H; Yang C; Wagner G; Shawver LK; Shet M; Ogilvie B; Madan A; Parkinson A
    Drug Metab Dispos; 2000 Dec; 28(12):1505-12. PubMed ID: 11095590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization of in vitro Caco-2 permeability and liver microsomal half-life screens in discovering BMS-488043, a novel HIV-1 attachment inhibitor with improved pharmacokinetic properties.
    Yang Z; Zadjura LM; Marino AM; D'Arienzo CJ; Malinowski J; Gesenberg C; Lin PF; Colonno RJ; Wang T; Kadow JF; Meanwell NA; Hansel SB
    J Pharm Sci; 2010 Apr; 99(4):2135-52. PubMed ID: 19780144
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of UDP-glucuronosyltransferase catalyzed formation of Picroside II glucuronide in microsomes of different species and recombinant UGTs.
    Li T; Zheng Y; Fu F; Ji H; Chen X; Zhao Y; Zhao D; Li N; Zhang L
    Xenobiotica; 2011 Jul; 41(7):530-7. PubMed ID: 21524190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of human pharmacokinetics--improving microsome-based predictions of hepatic metabolic clearance.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1427-31. PubMed ID: 17910819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Species differences in metabolism of panomifene, an analogue of tamoxifen.
    Monostory K; Jemnitz K; Vereczkey L; Czira G
    Drug Metab Dispos; 1997 Dec; 25(12):1370-8. PubMed ID: 9394026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug lipophilicity and microsomal protein concentration as determinants in the prediction of the fraction unbound in microsomal incubations.
    Gertz M; Kilford PJ; Houston JB; Galetin A
    Drug Metab Dispos; 2008 Mar; 36(3):535-42. PubMed ID: 18096674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.